Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.56
-0.5500-2.88%
Volume:13.31K
Turnover:246.75K
Market Cap:107.67M
PE:- -
High:18.62
Open:18.62
Low:18.51
Close:19.11
52wk High:21.88
52wk Low:14.38
Shares:5.80M
Float Shares:5.80M
Volume Ratio:3.37
T/O Rate:0.23%
Dividend:0.71
Dividend Rate:3.85%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut

Stock News
·
Aug 18

CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live
·
Aug 18

Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates

Deep News
·
Aug 18

Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer

Reuters
·
Aug 18

CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS
·
Aug 18

CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer

THOMSON REUTERS
·
Aug 18

WuXi Biologics Wins BioPharma APAC Spot on 2026 Sustainable Biopharma List

Reuters
·
Aug 18

WuXi XDC Secures GMP Release for BCM3 Bioconjugate Production Line in Singapore

Reuters
·
Aug 18

CSPC Innovation Posts RMB 1.26 Billion H1 Net Profit on RMB 3.24 Billion Revenue

Reuters
·
Aug 17

BlackRock Expands Stake in INNOVENT BIO with Recent Share Purchase

Stock News
·
Aug 17

CSPC Innovation Pharmaceutical H1 Net Profit 1.3 Billion Yuan

Reuters
·
Aug 17

Wuxi Biologics (Cayman) Stock Rises 2.3% in Hong Kong

Dow Jones
·
Aug 17

WuXi Biologics Agrees to Sell 51.1% Stake in Bestchrom

Reuters
·
Aug 17

JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each

Stock News
·
Aug 14

Everest Medicines Appoints Yue Wang as Non-Executive Director

Reuters
·
Aug 14

Wuxi Biologics (Cayman) Stock Sheds 1.3% in Hong Kong

Dow Jones
·
Aug 14

What Does Akeso (SEHK:9926) China Lung Cancer Approval Mean For Investors?

Simply Wall St.
·
Aug 14

Akari Net Loss Widens to $4.81 Million in Q2 FY26; Operating Loss Rises to $4.6 Million

Reuters
·
Aug 14

Beone Medicines Awards Over 40,000 Restricted Stock Units to Employees

Stock News
·
Aug 13

CSPC Pharmaceutical Group Stock Rallies 2.0% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 13